Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jones Medical Brevital sales total $2.4 mil. in last four months of 1995 -- offering prospectus.

Executive Summary

JONES MEDICAL BREVITAL SALES TOTALED $2.4 MIL. FOR LAST FOUR MONTHS OF 1995 following Jones Medical's acquisition of the general I.V. anesthetic agent from Lilly on Aug. 31, the company reports in a March 29 prospectus for a 2 mil.-share stock offering. Brevital (methohexital), used as both a short-acting anesthetic and an induction agent, was acquired in perpetuity by Jones for $14 mil. with a 5% royalty on net Brevital sales to be paid to Lilly for 10 years.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS028032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel